CDEK
← All organizations

Mission Pharmacal

For profitContributed to NME

Also known as: MISSION PHARMA | MISSION PHARMACAL | MISSION PHARMACAL CO

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2005

First marketed drug

Dec 22, 1971

First NDA

May 31, 1983

Last known activity

Jun 28, 2019

Timeline

1940s

  1. Jan 1, 1946

    Mission Pharmacal— Founded

1980s

  1. Aug 30, 1985

    potassium citrate— NDA Organization

2000s

  1. Jan 1, 2006

    Presutti Laboratories— Acquired

2010s

  1. Feb 18, 2011

    gabapentin— Marketing Organization

  2. Jan 1, 2015

    ProSolus Pharmaceuticals— Acquired

  3. Jun 28, 2019

    tiopronin— NDA Secondary Org

Drugs by trial phase (3 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (13)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (4)

Details

Founded
San Antonio, TX, US Jan 1, 1946
First NDA
May 31, 1983
Last known activity
Jun 28, 2019

Designations held

  • Orphan drug
  • Priority review